WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004004690) LIQUID DOSAGE FORMS OF PROTON PUMP INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/004690    International Application No.:    PCT/US2003/020946
Publication Date: 15.01.2004 International Filing Date: 02.07.2003
Chapter 2 Demand Filed:    03.02.2004    
IPC:
A61K 9/00 (2006.01), A61K 9/20 (2006.01), A61K 9/50 (2006.01), A61K 31/4439 (2006.01), A61K 47/12 (2006.01)
Applicants: ABBOTT LABORATORIES [US/US]; D-377 AP6A-1, 100 Abbott Park Road, Abbott Park, IL 60064-6008 (US)
Inventors: TANEJA, Rajneesh; (US)
Agent: YASGER, Paul, D; Dept 377/AP6A-1, 100 Abbott Park Road, Abbott Park, IL 60064-6008 (US)
Priority Data:
10/190,239 03.07.2002 US
Title (EN) LIQUID DOSAGE FORMS OF PROTON PUMP INHIBITORS
(FR) FORMES DOSIFIEES LIQUIDES TITRABLES DE MEDICAMENTS LABILES EN MILIEU ACIDE
Abstract: front page image
(EN)Provided herein are pharmaceutical formulations comprising micro-granules and a liquid suspension vehicle having a pH less than 6.0 and a viscosity sufficient to suspend the micro-granules. The micro-granules typically contain a PPI which therefore makes the above formulation, as well as kits for making the above formulation, useful for alleviating the symptoms of gastrointestinal disorders or diseases.
(FR)L'invention concerne des formulations pharmaceutiques comprenant des micro-granulés et un excipient liquide en suspension présentant un pH inférieur à 5,0 et une viscosité suffisante pour mettre lesdits micro-granulés en suspension. Lesdits micro-granulés contiennent généralement un IPP (inhibiteur de la pompe à protons) qui contribue de ce fait à la production de ladite formulation. L'invention concerne également des kits de production de ladite formulation servant à alléger les symptômes de troubles gastro-intestinaux ou de maladies associées.
Designated States: CA, JP, MX.
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR).
Publication Language: English (EN)
Filing Language: English (EN)